10-Q: AMN Healthcare Q2 Plunges on Demand Drop, Impairments
Quarterly Report
AMN Healthcare Services reported a significant net loss of $116.2 million in Q2 2025, driven by widespread revenue declines across segments and substantial goodwill and long-lived asset impairment charges.
Summary
- Revenue for the three months ended June 30, 2025, decreased by 11% to $658.2 million from $740.7 million in the prior year period.
- The company reported a net loss of $116.2 million for Q2 2025, a significant decline from a net income of $16.2 million in Q2 2024.
- Diluted earnings per share (EPS) fell to $(3.02) for Q2 2025, compared to $0.42 for Q2 2024.
- Goodwill impairment loss of $109.5 million was recognized in the Physician and Leadership Solutions segment.
- An impairment loss of $18.3 million was recognized for customer relationships intangible assets within the Nurse and Allied Solutions segment.
- Nurse and Allied Solutions segment revenue decreased by 14% to $381.9 million, primarily due to a 16% decrease in average travelers on assignment and a 2% decrease in average bill rate.
- Physician and Leadership Solutions segment revenue decreased by 6% to $174.5 million, with declines across all businesses, including a 9% decrease in locum tenens days filled and a 25% drop in interim leadership.
- Technology and Workforce Solutions segment revenue decreased by 9% to $101.8 million, mainly due to declines in VMS (down 31%) and outsourced solutions (down 46%).
- Gross profit decreased by 15% to $196.4 million for Q2 2025, with gross margins declining to 29.8% from 31.0% in Q2 2024.
- Net cash provided by operating activities for the six months ended June 30, 2025, was $171.2 million, a decrease from $180.9 million in the prior year period.
- The company completed the sale of its Smart Square healthcare scheduling software on July 1, 2025, for $65.3 million in cash and a $10 million note payable on January 1, 2027.
Sentiment
Score: 2
Explanation: The sentiment is highly negative due to significant revenue declines across all segments, a substantial net loss, and large goodwill and long-lived asset impairment charges. These factors indicate severe operational and financial challenges.
Positives
- Cash and cash equivalents increased to $41.5 million at June 30, 2025, from $10.6 million at December 31, 2024.
- Revolving credit facility borrowings decreased to $70.0 million at June 30, 2025, from $210.0 million at December 31, 2024.
- Labor disruption revenue increased by $15.0 million for the three months ended June 30, 2025, partially offsetting declines in other areas.
- Revenue per day filled in the locum tenens business increased by 9% for the three months ended June 30, 2025, compared to the prior year.
Negatives
- Net loss of $116.2 million for Q2 2025, compared to net income of $16.2 million for Q2 2024.
- Revenue decreased by 11% for Q2 2025 and 14% for the six months ended June 30, 2025, across all segments.
- Goodwill impairment loss of $109.5 million recognized in the Physician and Leadership Solutions segment.
- Long-lived assets impairment loss of $18.3 million recognized for customer relationships intangible assets.
- Gross margin declined to 29.8% in Q2 2025 from 31.0% in Q2 2024, driven by increased provider pay packages and a shift in sales mix.
- Operating income shifted to a loss of $123.7 million in Q2 2025 from an income of $37.7 million in Q2 2024.
- Average number of travelers on assignment decreased by 16% in Q2 2025, and average bill rate decreased by 2% in the Nurse and Allied Solutions segment.
- Demand for interim leadership and executive search services declined by 25% and 29% respectively in Q2 2025.
- VMS business revenue declined by 31% and outsourced solutions by 46% in Q2 2025 due to lower demand and prior year client losses.
- Language services growth slowed due to reduced minute growth and lower pricing from increased market competition.
Risks
- Clients increasing efficiency, hiring permanent staff, and implementing cost management strategies may negatively affect revenue, results of operations, and cash flows.
- Economic downturns, inflation, recession, or governmental policy uncertainty could reduce demand for services and increase client cost-containment initiatives.
- Inability to anticipate and quickly respond to changing marketplace conditions, such as alternative healthcare delivery models or client needs.
- Consolidation and concentration of healthcare workforce buyers could affect service pricing and ability to mitigate concentration risk.
- Investigations, claims, and legal proceedings alleging medical malpractice, anti-competitive conduct, or violations of employment, privacy, and wage regulations could lead to substantial liabilities.
- Changes in United States immigration laws and policies, including visa retrogression, could impact the ability to staff healthcare professionals.
- Challenges to the classification of healthcare professionals as independent contractors could adversely affect profitability.
- Inability to recruit and retain sufficient quality healthcare professionals at reasonable costs could increase operating costs and negatively affect business.
- Technology disruptions or inability to implement new infrastructure and technology systems effectively may adversely affect operating results.
- Failure to further develop workforce solutions technology offerings and capabilities, or increased competition, may harm the business.
- Security breaches and cybersecurity incidents could compromise information and systems, affecting business operations, reputation, and leading to substantial liabilities.
- Widespread use of artificial intelligence (AI) could impact the business model.
- Indebtedness could adversely affect the ability to raise additional capital, limit reaction to market changes, and expose to interest rate risk.
Future Outlook
The company anticipates its annual effective tax rate to be approximately 13% for 2025. Management believes that cash generated from operations and available borrowings under the Senior Credit Facility will be sufficient to fund operations and liquidity requirements for the next 12 months and beyond. The company intends to finance potential future acquisitions through a combination of internally generated cash, borrowings, and debt or equity offerings. The company is currently assessing the impact of the recently enacted One Big Beautiful Bill Act (OBBBA) on its consolidated financial statements.
Management Comments
- Healthcare organizations are focusing on hiring permanent staff, implementing cost management strategies, and exploring alternative staffing models to decrease reliance on contingent labor.
- Uncertainty about government policy impacts appeared to place the healthcare sector in a more conservative stance compared with the first quarter.
- Travel nurse business demand decreased in the second quarter compared to the first quarter due to regular seasonal fluctuations and lower overall market demand, with open orders dropping below the previous year and remaining below pre-pandemic levels.
- Visa retrogression is affecting international nurse staffing, contributing to a decrease in overall staffing volume.
- Demand for interim leadership and search services declined due to healthcare organizations delaying hiring, consolidating roles, or increasing insourcing.
- Growth in the language services business has slowed due to reduced minute growth and lower pricing, a result of increased market competition.
Industry Context
The healthcare staffing industry is experiencing a significant shift post-COVID-19, with healthcare organizations prioritizing permanent staff hiring, cost containment, and alternative staffing models. This trend is leading to decreased demand for contingent labor, particularly travel nurses, which is impacting staffing firms. Increased market competition is also driving pricing pressures in technology-enabled services like language interpretation. Regulatory changes, such as visa retrogression, further complicate international staffing efforts, while broader economic uncertainties contribute to a more conservative hiring environment within the healthcare sector.
Comparison to Industry Standards
- NA
Legal Proceedings
- Involvement in various lawsuits, claims, investigations, and proceedings in the ordinary course of business, including professional liability, tax, compensation, contract, competitor disputes, and employee-related matters.
- Significant matters include class and representative actions related to wage and hour claims under California and Federal law.
- Potential indemnification obligations under contracts with clients relating to claims, governmental inquiries, and legal actions against clients for services provided by the company's healthcare professionals.
Stakeholder Impact
- Shareholders: Significant negative impact due to substantial net losses, goodwill and long-lived asset impairments, and declining revenue, likely leading to decreased share price and reduced shareholder equity.
- Employees: Lower employee compensation and benefits in response to reduced revenue, potentially impacting morale and retention.
- Customers: Potential impact from reduced service offerings (e.g., Smart Square sale) and declining volumes in VMS and outsourced solutions, though the company aims to optimize workforce solutions.
- Creditors: While debt outstanding on the revolving credit facility decreased, the significant losses and impairments could raise concerns about future financial health and covenant compliance, despite management's confidence in liquidity.
Next Steps
- Continue to evaluate estimates related to goodwill and intangible assets, asset impairments, self-insurance accruals, contingent liabilities, and income taxes.
- Assess the impact of the One Big Beautiful Bill Act (OBBBA) on consolidated financial statements.
- Potentially pursue future acquisitions, financed by cash from operations, borrowings under the Senior Credit Facility, or other debt/equity offerings.
- The Board-authorized share repurchase program remains active with $226.7 million remaining, though no shares were repurchased in the first six months of 2025.
Key Dates
| Date | Description |
|---|---|
| 2016-11-01 | Board authorized a $150.0 million share repurchase program. |
| 2021-11-10 | Share repurchase program increased. |
| 2022-02-17 | Share repurchase program increased. |
| 2022-06-15 | Share repurchase program increased. |
| 2023-02-16 | Share repurchase program increased. |
| 2023-11-05 | Entered into the Fourth Amendment to the credit agreement, increasing the consolidated net leverage ratio covenant for 2025. |
| 2023-12-15 | Effective date for ASU 2023-07 (Segment Reporting) for fiscal years beginning after this date. |
| 2024-12-15 | Effective date for ASU 2023-09 (Income Tax Disclosures) for fiscal years beginning after this date. |
| 2025-01-01 | Released $25.0 million of restricted cash from captive insurance subsidiary to repay Senior Credit Facility. |
| 2025-06-30 | End of the quarterly reporting period. |
| 2025-07-01 | Completed the sale of Smart Square healthcare scheduling software to Symplr Software LLC. |
| 2025-07-04 | The One Big Beautiful Bill Act (OBBBA) was enacted in the United States. |
| 2025-08-05 | Date of common stock outstanding count (38,324,255 shares). |
| 2025-08-07 | Date of signing for the Form 10-Q. |
| 2026-12-15 | Effective date for ASU 2024-03 (Income Statement Expense Disaggregation) for fiscal years beginning after this date. |
| 2027-01-01 | Payment due date for the $10.0 million note from the Smart Square sale. |
Recommendation
strong sellThe company reported a substantial net loss of $116.2 million for the quarter, a dramatic reversal from prior year's profit, driven by widespread revenue declines across all segments and significant impairment charges totaling over $127 million. Key business segments like Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions all experienced revenue drops and margin compression. The outlook suggests continued challenges with declining demand for contingent labor, increased competition, and regulatory hurdles. These factors indicate severe operational headwinds and a deteriorating financial position, making the stock a strong sell for investors.
Keywords
Healthcare staffing, Workforce solutions, Nurse staffing, Locum tenens, Vendor management systems, Healthcare technology, Talent acquisition, Goodwill impairment, Financial results, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.